Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 9;55(1):450–455. doi: 10.1080/13880209.2016.1247879

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Expression level of caveolin-1 (Cav-1) in rat lung tissues. (a) Relative mRNA expression level of Cav-1 determined by real-time quantitative PCR. #, P < 0.01, compared with the C group; **, P < 0.01, compared with the M group; *, P < 0.05, compared with the M group; +, P < 0.01, compared with the H group; ++, P > 0.05, compared with the H group; Δ, P > 0.05, compared with the N group. (b) Protein expression level of Cav-1 determined by Western blot. #, P < 0.01, compared with the C group; *, P < 0.01, compared with the M group; +, P > 0.05, compared with the H group; ▼, P < 0.05, compared with the N group. C, the control group that is not induced into idiopathic pulmonary fibrosis; M, the model group that has been induced into idiopathic pulmonary fibrosis; P, the idiopathic pulmonary fibrosis model group that is treated by pirfenidone; H, the idiopathic pulmonary fibrosis model group that is treated by prednisone; N, the idiopathic pulmonary fibrosis model group that is treated by acetylcysteine..